NEW YORK (GenomeWeb) – A Chinese research team has narrowed in on a tumor gene expression-signature that appears to distinguish glioblastoma patients with better or worse overall survival times, independent of other potential prognostic predictors such as treatment type.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.